✦ LIBER ✦

The benefits of adjuvant hormonal therapy in patients with early breast cancer 35 years old or younger

✍ Scribed by N Snoj; B Pajk; S Bostnar; T Cufer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of aromatase inhibitors in the upfr

✍ Jean-Marc Nabholtz; Marie-Ange Mouret-Reynier; Xavier Durando; Isabelle Van Praa 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

49 Breast Cancer in Patients 40 Years Ol

✍ A. Boukerche; R. Madouri; H. Belmiloud; M. Benarbia; A. Yahia; A.F. Dali-Youcef 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Optimizing the use of aromatase inhibito

✍ Walter Jonat; Felix Hilpert 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 412 KB

392 PUBLICATION 3-year survival of the p

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Adherence to adjuvant hormone therapy in

✍ Yihang Liu, Jennifer L. Malin, Allison L. Diamant, Amardeep Thind, Rose C. Maly 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 194 KB

345 High Level of Ki67 (≥10%) is Not a A

✍ Y. Jeeman; H. Wonshik; M. Hyeong Gon; A. Soo Kyung; S. Hee Chul; K. Ji Sun; N. D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB